According to its annual report, the average length of relationships with its top 25 clients, as measured by revenue, is over 25 years and its retention rate for its top 1,000 clients from 2014 to 2015 was 99%.Ĭustomers are able to contact IMS Health directly through its website, as well as over the phone, receiving personal care for any issues and enquiries. IMS Health maintains long-standing relationships and high renewal rates with its clients, due in part to the nature of the services and solutions its provides. This allows the Company to provide a more personalised service that fully covers the client’s brief. Instead, the Company implements a predominantly direct sales model, with customers consulting directly with members of the Company’s local sales teams before making purchases. While the Company has an online presence, it does not appear to provide services and solutions on a self-service basis. IMS Health also sells a portion of its products and solutions to distributors, which sell on to end-users, and collaborates with a network of other channel partners. The Company has a sales presence across North America, Latin America, Europe, and Asia, including offices in Buenos Aires, Caracas, Los Ruices, Lisbon, and Bangalore The majority of IMS Health’s sales are made directly via its in-house sales teams, which are organised by jurisdiction, managing sales and customer relationships on a local basis. The Company, however, does not appear to operate an online sales channel. IMS Health operates a website at where customers are able to find information on the Company’s services and solutions. Its commitment to innovation, with the Company devoting substantial resources to research and development activities each year.Its flexible and scalable products and solutions, which can be implemented across businesses of all sizes and in various jurisdictions and.The quality and efficiency of its products and services, comprising a diverse suite of solutions developed by in-house experts with the support of market-leading technology partners.Its industry standing and brand identity, being one of the largest companies in its sector and having a number of longstanding client relationships with high-profile customers.IMS Health provides value to its customers in the following ways:
The Company, however, also serves customers across more than 100 countries worldwide, with business in emerging markets such as China, India, Brazil and Russia growing significantly in recent years. IMS Health’s largest market is its native US, which accounted for around 39% of the Company’s 2015 revenue. Sales to government agencies represent only around 1% of the Company’s business. IMS Health also serves medical product distributors, government and regulatory agencies, pharmaceutical distributors, financial services firms, and pharmacies. Its customer base comprises a broad range of companies within the sector, with around 90% of its sales coming from:Īccording to the Company’s annual report, it includes almost all of the top 100 pharmaceutical and biotechnology companies, measured by revenue, among its clients, many of which subscribe to products and services across multiple jurisdictions.
IMS Health provides information and technology services to organisations operating within the healthcare sector. IMS Health has a current market capitalization of $9.98 billion.īusiness model of IMS Health Customer Segments The Company was again listed on the New York Stock Exchange in 2014, raising $1.4 billion in its initial public offering, making it the second largest listing of the year. IMS Health was listed on the New York Stock Exchange in 1998, but was made a private company in 2010 by TPG Capital, CPP Investment Board and Leonard Green & Partners.
#Ims health moneyhouse series
IMS Health expanded its geographic reach and made a series of strategic acquisitions throughout the latter half of the 20 th Century – including acquisitions of Pharmatech, Cambridge Computer, and Armbruster, Moore and MacKerell – and began developing online solutions. The Company published its first European syndicated research study in 1957, focused on pharmaceutical sales in West Germany, which was followed by similar studies across Italy, Japan, the UK, Australia and South Africa. It operated initially as a market research company that aimed to enable organisations to make informed, strategic decisions. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. IMS Health aims to provide technology services and solutions to companies operating within the global healthcare sector, enabling them to more efficiently and effectively manage their operations.
0 kommentar(er)
